High concentration of C-type natriuretic peptide promotes VEGF-dependent vasculogenesis in the remodeled region of infarcted swine heart with preserved left ventricular ejection fraction

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2426-2434

  Del Ry, S ^a   Cabiati, M ^a   Martino, A ^b   Cavallini, C ^c   Caselli, C ^a   Aquaro, G D ^d   Battolla, B ^b   Prescimone, T ^a   Giannessi, D ^a   Mattii, L ^b   Lionetti, V ^c,d,e  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CNR   (Italy)

^e SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

C type natriuretic peptide; Ischemic remodeling; Myocardial infarction; Paracrinicity; Vasculogenesis; VEGF

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; METALLOPROTEINASE; NATRIURETIC PEPTIDE TYPE C; VASCULOTROPIN; VASCULOTROPIN A; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SWINE; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, C-TYPE; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84885605197     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.015     Document Type: Article

References (48)

1. B.A. Steinberg, X. Zhao, and P.A. Heidenreich Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction - prevalence, therapies, and outcomes Circulation 126 2012 65 75
2. M.G. Sutton, and N. Scarpe Left ventricular remodeling after myocardial infarction: pathophysiology and therapy Circulation 101 2000 2981 2988
3. V. Lionetti, G. Bianchi, F.A. Recchia, and C. Ventura Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure Heart Fail Rev 15 2010 531 542
4. H. Kubo, N. Jaleel, and A. Kumarapeli Increased cardiac myocyte progenitors in failing human hearts Circulation 118 2008 649 657
5. S.P. Levick, G.C. Meléndez, and E. Plante Cardiac mast cells: the centrepiece in adverse myocardial remodelling Cardiovasc Res 89 2011 12 19
6. Zhang Y, Elsik M, Edgley AJ, et al. A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction. Int J Cardiol 2012. http://dx.doi.org/10.1016/j.ijcard.2012.11.067.
7. S.C. Tyagi Vasculogenesis and angiogenesis: extracellular matrix remodeling in coronary collateral arteries and the ischemic heart J Cell Biochem 65 1997 388 394
8. J. Hsia, K.A. Jablonski, and M.M. Rice Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function Am J Cardiol 101 2008 457 461
9. M.J. de Boer, H. Suryapranata, and J.C. Hoorntje Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction Circulation 90 1994 753 761
10. S. Banai, D. Shweiki, and A. Pinson Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis Cardiovasc Res 28 1994 1176 1179
11. R.A. van Liebergen, J.J. Piek, and K.T. Koch Quantification of collateral flow in humans: a comparison of angiographic, electrocardiographic and hemodynamic variables J Am Coll Cardiol 33 1999 670 677
12. D.S. Burley, S.A. Hamid, and G.F. Baxter Cardioprotective actions of peptide hormones in myocardial ischemia Heart Fail Rev 12 2007 279 291
13. M. Mukoyama, K. Nakao, and K. Obata Augmented secretion of brain natriuretic peptide in acute myocardial infarction Biochem Biophys Res Commun 180 1991 431 436
14. S. Del Ry, M. Cabiati, and F. Vozzi Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes Peptides 32 2011 1713 1718
15. C.J. Kelsall, A.H. Chester, and P. Sarathchandra Expression and localization of C-type natriuretic peptide in human vascular smooth muscle cells Vascul Pharmacol 45 2006 368 373
16. C.F. Liang, A.L. Au, and S.W. Leung Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing bigconductance calcium-activated potassium channels of vascular smooth muscle J Pharmacol Exp Ther 334 2010 223 231
17. C. Calvieri, S. Rubattu, and M. Volpe Molecular mechanisms underlying cardiac anti-hypertrophic and antifibrotic effects of natriuretic peptides J Mol Med (Berl) 90 2012 5 13
18. S. Del Ry, M. Cabiati, V. Lionetti, and D. Giannessi NPR-B, the C-type natriuretic peptide specific receptor, is the predominant biological receptor in mouse and pig myocardial tissue Minerva Endocrinol 35 2010 37 46
19. E. Qvigstad, L.R. Moltzau, and J.M. Aronsen Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition Cardiovasc Res 85 2010 763 772
20. Y. Wang, M.C. de Waard, and A. Sterner-Kock Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice Eur J Heart Fail 9 2007 548 557
21. T. Soeki, I. Kishimoto, and H. Okumura C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction J Am Coll Cardiol 45 2005 608 616
22. S. Del Ry, M. Cabiati, and V. Lionetti Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure Peptides 30 2009 1710 1713
23. A. Simioniuc, M. Campan, and V. Lionetti Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study Cardiovasc Res 90 2011 546 556
24. V. Lionetti, L. Guiducci, and A. Simioniuc Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure Am J Physiol Heart Circ Physiol 293 2007 H2747 H2756
25. V. Lionetti, G.D. Aquaro, and A. Simioniuc Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure J Card Fail 15 2009 920 928
26. S. Del Ry, M. Cabiati, and V. Lionetti Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa Peptides 28 2007 1390 1396
27. S. Del Ry, M. Cabiati, V. Lionetti, M. Emdin, F.A. Recchia, and D. Giannessi Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart Peptides 29 2008 2008 2015
28. M. Cabiati, M. Campan, C. Caselli, T. Prescimone, D. Giannessi, and S. Del Ry Sequencing and cardiac expression of natriuretic peptide receptors A and C in normal and heart failure pigs Regul Pept 162 2010 12 17
29. V. Lionetti, S. Cantoni, and C. Cavallini Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation J Biol Chem 285 2010 9949 9961
30. C. Johnson, H.J. Sung, S.M. Lessner, M.E. Fini, and Z.S. Galis Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching Circ Res 94 2004 262 268
31. J. Vandesompele, K. De Preter, and F. Pattyn Accurate normalization of real-timequantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 [RESEARCH0034]
32. A. Martino, M. Cabiati, and M. Campan Selection of reference genes for normalization of RT-PCR data in minipig Heart Failure model and evaluation of TNF-α mRNA expression J Biotechnol 153 2011 92 99
33. T.M. Grass, D.I. Lurie, and J.D. Coffin Transitional angiogenesis and vascular remodeling during coronary angiogenesis in response to myocardial infarction Acta Histochem 108 2006 293 302
34. L. Zentilin, U. Puligadda, and V. Lionetti Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction FASEB J 24 2010 1467 1478
35. M. Ferrarini, N. Arsic, and F.A. Recchia Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs Circ Res 98 2006 954 961
36. C. Zellner, A.A. Protter, and E. Ko Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries Am J Physiol 276 1999 H1049 H1057
37. A. Hobbs, P. Foster, C. Prescott, R. Scotland, and A. Ahluwalia Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial Ischemia/reperfusion Injury Novel cardioprotective role for endothelium-derived C-type natriuretic Circulation 110 2004 1231 1235
38. S.P. D'Souza, M. Davis, and G.F. Baxter Autocrine and paracrine actions of natriuretic peptides in the heart Pharmacol Ther 101 2004 113 129
39. S. Orn, C. Manhenke, and O.J. Greve Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention Eur Heart J 30 2009 1978 1985
40. T. Etoh, C. Joffs, and A.M. Deschamps Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs Am J Physiol Heart Circ Physiol 281 2001 H987 H994
41. S. Miyazaki, T. Kasai, and K. Miyauchi Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both Circ J 74 2010 1158 1164
42. A.M. Romanic, S.M. Harrison, and W. Bao Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9 Cardiovasc Res 54 2002 549 558
43. T. Zhao, W. Zhao, Y. Chen, R.A. Ahokas, and Y. Sun Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction Microvasc Res 80 2010 188 194
44. Y. Ishikawa, Y. Akasaka, and T. Ishii Sequential changes in localization of repair-related proteins (heat shock protein 70, ubiquitin and vascular endothelial growth factor) in the different stages of myocardial infarction Histopathology 37 2000 546 554
45. G. Tarantini, R. Razzolini, and L. Cacciavillani Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty Am J Cardiol 98 2006 1033 1040
46. A. Lombardo, G. Niccoli, and L. Natale Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction: a contrast-enhanced cardiac magnetic resonance imaging study Int J Cardiovasc Imaging 28 2012 835 842
47. K. Doi, H. Itoh, and Y. Komatsu Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion Hypertension 27 1996 811 815
48. T. Chen, G. Zhou, and Q. Zhu Overexpression of vascular endothelial growth factor 165 (VEGF165) protects cardiomyocytes against doxorubicin-induced apoptosis J Chemother 22 2010 402 406